These results emphasize the role of exosomal HMGB1 in promoting ESCC radioresistance by activating the PI3K/AKT/FOXO3A and facilitating DNA damage repair, positioning it as a novel biomarker and therapeutic target in radiation response modulation. The gene discussed is HMGB1; the disease is esophageal squamous cell carcinoma.